Conduit Pharmaceuticals Inc (NASDAQ:CDT) has a beta value of 2.17 and has seen 8.1 million shares traded in the recent trading session. The company, currently valued at $9.36M, closed the recent trade at $0.09 per share which meant it lost -$0.01 on the day or -9.23% during that session. The CDT stock price is -8600.0% off its 52-week high price of $7.83 and 11.11% above the 52-week low of $0.08. If we look at the company’s 10-day average daily trading volume, we find that it stood at 66.03 million shares traded. The 3-month trading volume is 21.89 million shares.
Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information
Sporting -9.23% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the CDT stock price touched $0.09 or saw a rise of 43.0%. Year-to-date, Conduit Pharmaceuticals Inc shares have moved -97.93%, while the 5-day performance has seen it change 2.72%. Over the past 30 days, the shares of Conduit Pharmaceuticals Inc (NASDAQ:CDT) have changed -15.79%. Short interest in the company has seen 3.57 million shares shorted with days to cover at 0.14.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CDT Dividends
Conduit Pharmaceuticals Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders
Insiders own 49.12% of the company shares, while shares held by institutions stand at 4.06% with a share float percentage of 7.97%. Investors are also buoyed by the number of investors in a company, with Conduit Pharmaceuticals Inc having a total of 52.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund. As of Aug 31, 2024, the former fund manager holds about 0.23% shares in the company for having 233.35 shares of worth $21958.0 while later fund manager owns 202.93 shares of worth $19096.0 as of Jun 30, 2024, which makes it owner of about 0.20% of company’s outstanding stock.
